Abstract

BackgroundNuclear bodies, such as nucleoli, PML bodies, and SC35 speckles, are dynamic sub-nuclear structures that regulate multiple genetic and epigenetic processes. Additional regulation is provided by RNA/DNA handling proteins, notably TDP-43 and FUS, which have been linked to ALS pathology. Previous work showed that mouse cell line myotubes have fewer but larger nucleoli than myoblasts, and we had found that nuclear aggregation of TDP-43 in human myotubes was induced by expression of DUX4-FL, a transcription factor that is aberrantly expressed and causes pathology in facioscapulohumeral dystrophy (FSHD). However, questions remained about nuclear bodies in human myogenesis and in muscle disease.MethodsWe examined nucleoli, PML bodies, SC35 speckles, TDP-43, and FUS in myoblasts and myotubes derived from healthy donors and from patients with FSHD, laminin-alpha-2-deficiency (MDC1A), and alpha-sarcoglycan-deficiency (LGMD2D). We further examined how these nuclear bodies and proteins were affected by DUX4-FL expression.ResultsWe found that nucleoli, PML bodies, and SC35 speckles reorganized during differentiation in vitro, with all three becoming less abundant in myotube vs. myoblast nuclei. In addition, though PML bodies did not change in size, both nucleoli and SC35 speckles were larger in myotube than myoblast nuclei. Similar patterns of nuclear body reorganization occurred in healthy control, MDC1A, and LGMD2D cultures, as well as in the large fraction of nuclei that did not show DUX4-FL expression in FSHD cultures. In contrast, nuclei that expressed endogenous or exogenous DUX4-FL, though retaining normal nucleoli, showed disrupted morphology of some PML bodies and most SC35 speckles and also co-aggregation of FUS with TDP-43.ConclusionsNucleoli, PML bodies, and SC35 speckles reorganize during human myotube formation in vitro. These nuclear body reorganizations are likely needed to carry out the distinct gene transcription and splicing patterns that are induced upon myotube formation. DUX4-FL-induced disruption of some PML bodies and most SC35 speckles, along with co-aggregation of TDP-43 and FUS, could contribute to pathogenesis in FSHD, perhaps by locally interfering with genetic and epigenetic regulation of gene expression in the small subset of nuclei that express high levels of DUX4-FL at any one time.

Highlights

  • Nuclear bodies, such as nucleoli, PML bodies, and SC35 speckles, are dynamic sub-nuclear structures that regulate multiple genetic and epigenetic processes

  • Nucleoli reorganize during myogenesis and are not affected by DUX4-FL In cultures of myogenic cells from human healthy controls, we identified nucleoli by immunofluorescence staining for nucleolin and found that myoblast nuclei typically contained about three to six small nucleoli, whereas myotube nuclei typically contained one to three nucleoli (Fig. 1a–c)

  • To determine if nucleolar reorganization was affected by disease, we examined nucleolar numbers and crosssectional areas in cultures of myogenic cells from MDC1A, limb-girdle muscular dystrophy type 2D (LGMD2D), and facioscapulohumeral dystrophy (FSHD) donors (Fig. 1c, d)

Read more

Summary

Introduction

Nuclear bodies, such as nucleoli, PML bodies, and SC35 speckles, are dynamic sub-nuclear structures that regulate multiple genetic and epigenetic processes. Previous work showed that mouse cell line myotubes have fewer but larger nucleoli than myoblasts, and we had found that nuclear aggregation of TDP-43 in human myotubes was induced by expression of DUX4-FL, a transcription factor that is aberrantly expressed and causes pathology in facioscapulohumeral dystrophy (FSHD). We show that multiple sub-nuclear structures (i.e., nuclear bodies) reorganize during myotube formation in primary cultures of human myogenic cells. We further examine how nuclear bodies and additional nuclear proteins are affected by disease, using cultures of myogenic cells obtained from patients with muscle diseases. FSHD type 1 is caused by genetic and epigenetic changes that promote aberrant expression of a full-length isoform of DUX4 (DUX4-FL), which is a highly cytotoxic transcription factor with a double homeodomain region [4, 8, 9]. A shorter isoform, DUX4-S, that lacks the C-terminal transactivation domain but retains the two homeodomains, is much less cytotoxic [10,11,12]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call